|
|
|
Volumn , Issue 100, 1999, Pages 19-20
|
|
Causes of death in the ATLAS study: Effects of high-dose ACE inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LISINOPRIL;
ADULT;
AGED;
CAUSE OF DEATH;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUDDEN DEATH;
ARTICLE;
CONGESTIVE HEART FAILURE;
MORTALITY;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CAUSE OF DEATH;
DEATH, SUDDEN, CARDIAC;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
LISINOPRIL;
MYOCARDIAL INFARCTION;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 33749195154
PISSN: 1368504X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
